TG THERAPEUTICS INC. - COMMON STOCK
35.07
22-November-24 16:44:58
15 minutes delayed
Stocks
+0.52
+1.51%
Today's range
33.71 - 35.32
ISIN
N/A
Source
NASDAQ
-
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)
05 Feb 2021 13:54:45 By Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the B. Riley Securities Oncology Investor Conference
15 Jan 2021 07:00:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
08 Jan 2021 07:00:00 By Nasdaq GlobeNewswire